Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2885977 | Annals of Vascular Surgery | 2015 | 7 Pages |
Abstract
The overall EVAR procedural duration, fluoroscopy time, and volume of contrast medium infusion were significantly reduced in the group treated with the unibody endografts. These results seem to suggest that the unibody endograft may reduce patient risk of nephrotoxic action of the contrast medium, especially important in patients with existing renal insufficiency, and may reduce ionizing radiation exposure for both the patients and operators.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Roberto Silingardi, Ilaria Azzoni, Enrico Giuliani, Giuseppe Saitta, Stefano Gennai, Gioachino Coppi,